EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Apolipoprotein D Expression Dynamics During Cuprizone-Induced Demyelination and Remyelination in a Mouse Model of Multiple Sclerosis

Eva Martínez-Pinilla iD, Nuria Rubio-Sardón iD, Gemma Fernández-García iD, Sandra Villar-Conde, Carlota Menéndez-Pérez iD, Jorge Tolivia iD, Eva Del Valle iD, Ana Navarro iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26178692 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Eva Martínez-Pinilla und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Morphology and Cell Biology, University of Oviedo, 33006 Oviedo, Spain. Hauptthemen laut MEDLINE: Cuprizone, Remyelination, Demyelinating Diseases, Multiple Sclerosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 139 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Spanish National Instituto de Salud Carlos III, Co-funded by European Regional Development Fund and European Social Fund "Investing in your future", Fondo de Investigaciones Sanitarias (FIS), European Regional Development Fund and European Social Fund “Investing in your future”.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple sclerosis (MS) is a chronic, immune-mediated disease of the central nervous system (CNS) characterized by oligodendrocyte (OLG) degeneration, myelin loss, and impaired remyelination. Apolipoprotein D (Apo D), a glia-derived lipocalin, has emerged in recent decades as a neuroprotective molecule involved in lipid transport, oxidative stress regulation, and inflammation control during aging and neurodegenerative diseases like MS. However, its role in demyelination/remyelination dynamics remains poorly defined. In this study, we used the cuprizone (CPZ)-induced demyelination model in C57BL/6 mice to analyze Apo D expression patterns in the corpus callosum during de- and remyelination. We also assessed whether the atypical antipsychotic clozapine (CLO), previously shown to upregulate Apo D in vivo, could modulate its expression and influence myelin recovery in this pathological context. Using a combination of magnetic resonance imaging, Luxol fast blue staining, and double immunohistochemistry, we demonstrated that CPZ treatment for 3 or 6 weeks led to significant demyelination, hydrocephalus, and reduced motor cortex thickness, which were partially reversed after treatment cessation. Apo D expression in OLGs was significantly reduced by CPZ exposure, both at the protein level and in terms of immunoreactive cell counts, but was restored following treatment withdrawal. Notably, co-administration of CLO prevented the CPZ-induced reduction in Apo D expression in OLGs, although it did not attenuate myelin loss. In this way, our results reveal a strong correlation between Apo D expression and OLG/myelin integrity in vivo. While CLO did not exert remyelinating effects, it preserved Apo D levels under demyelinating conditions, suggesting a potential indirect neuroprotective mechanism. These findings support the relevance of Apo D in CNS myelin homeostasis and highlight its potential as a molecular target for therapeutic intervention in demyelinating diseases such as MS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CuprizoneRemyelinationDemyelinating DiseasesMultiple SclerosisApolipoproteins DAnimalsMiceDisease Models, AnimalMice, Inbred C57BLMyelin SheathOligodendrogliaCorpus CallosumMaleClozapine

Stichwörter der Autor:innen

apolipoprotein Dclozapinecuprizonemultiple sclerosisneuroprotectionoligodendrocytesremyelination

Substanzen

CuprizoneApolipoproteins DClozapine

Autor:innen und Institutionen

  • Department of Morphology and Cell Biology, University of Oviedo, 33006 Oviedo, Spain.
  • Instituto de Neurociencias del Principado de Asturias (INEUROPA), 33006 Oviedo, Spain.
  • Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33006 Oviedo, Spain.
  • Department of Functional Biology, University of Oviedo, 33006 Oviedo, Spain.
  • Instituto Universitario de Oncología del Principado de Asturias (IUOPA), 33006 Oviedo, Spain.

ORCID-Profile: Eva Martínez-Pinilla, Nuria Rubio-Sardón, Gemma Fernández-García, Carlota Menéndez-Pérez, Jorge Tolivia, Eva Del Valle, Ana Navarro

Förderung

  • Spanish National Instituto de Salud Carlos III, Co-funded by European Regional Development Fund and European Social Fund "Investing in your future"
  • Fondo de Investigaciones Sanitarias (FIS)
  • European Regional Development Fund and European Social Fund “Investing in your future”

Zitieren

APA

Martínez-Pinilla, E., Rubio-Sardón, N., Fernández-García, G., Villar-Conde, S., Menéndez-Pérez, C., Tolivia, J., Del Valle, E., & Navarro, A. (2025). Apolipoprotein D Expression Dynamics During Cuprizone-Induced Demyelination and Remyelination in a Mouse Model of Multiple Sclerosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26178692

Vancouver

Martínez-Pinilla E, Rubio-Sardón N, Fernández-García G, Villar-Conde S, Menéndez-Pérez C, Tolivia J, et al. Apolipoprotein D Expression Dynamics During Cuprizone-Induced Demyelination and Remyelination in a Mouse Model of Multiple Sclerosis. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26178692

BibTeX
@article{MartnezPinilla2025,
  author = {Martínez-Pinilla, Eva and Rubio-Sardón, Nuria and Fernández-García, Gemma and Villar-Conde, Sandra and Menéndez-Pérez, Carlota and Tolivia, Jorge and Del Valle, Eva and Navarro, Ana},
  title = {Apolipoprotein D Expression Dynamics During Cuprizone-Induced Demyelination and Remyelination in a Mouse Model of Multiple Sclerosis},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26178692}
}
Kostenlos starten →